Probiogen AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Probiogen AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C7541
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Probiogen AG (Probiogen) a subsidiary of Minapharm Pharmaceuticals & Chemical Industries is a contract development and manufacturing organization that offers cell line engineering, process development and GMP manufacturing of biopharmaceuticals. The organization’s services comprise therapeutic proteins/antibodies, viral vaccines, biosimilar and biobetter development. It offers contract cell line development, contract process development, contract manufacturing of GMP and non-GMP, protein analytics, and cell-based assays. It develops various technologies for optimized biopharmaceutical manufacturing and analysis. The organization also develops virusproduction system, adcc enhancement, yield enhancement, innovative bioassays and other technologies. Probiogen is headquartered in Berlin, Germany.

Probiogen AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Probiogen AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Probiogen AG, Medical Devices Deals, 2012 to YTD 2018 9
Probiogen AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Probiogen AG, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
ProBioGen Enters into Agreement with Tizona Therapeutics 11
ProBioGen Enters into Agreement with Surface Oncology 12
ProBioGen Enters into Co-Development Agreement with PT Bio Farma 13
ProBioGen Enters into Agreement with Zymeworks 14
Licensing Agreements 15
Nouscom Enters into Licensing Agreement with ProBioGen 15
Chiome Bioscience Enters into Licensing Agreement with ProBioGen 16
ProBioGen Enters into Licensing Agreement with Eucodis Bioscience 17
ProBioGen Enters into Licensing Agreement with Merus 18
ProBioGen Enters into Licensing Agreement with Tizona Therapeutics 19
ProBioGen Enters into Lincencing Agreement with Novartis for GlymaxX ADCC Technology 20
ProBioGen Enters Into Licensing Agreement With Merus For GlymaxX ADCC Technology 21
Probiogen AG – Key Competitors 22
Probiogen AG – Key Employees 23
Probiogen AG – Locations And Subsidiaries 24
Head Office 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Probiogen AG, Pharmaceuticals & Healthcare, Key Facts 2
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Probiogen AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Probiogen AG, Deals By Therapy Area, 2012 to YTD 2018 8
Probiogen AG, Medical Devices Deals, 2012 to YTD 2018 9
Probiogen AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ProBioGen Enters into Agreement with Tizona Therapeutics 11
ProBioGen Enters into Agreement with Surface Oncology 12
ProBioGen Enters into Co-Development Agreement with PT Bio Farma 13
ProBioGen Enters into Agreement with Zymeworks 14
Nouscom Enters into Licensing Agreement with ProBioGen 15
Chiome Bioscience Enters into Licensing Agreement with ProBioGen 16
ProBioGen Enters into Licensing Agreement with Eucodis Bioscience 17
ProBioGen Enters into Licensing Agreement with Merus 18
ProBioGen Enters into Licensing Agreement with Tizona Therapeutics 19
ProBioGen Enters into Lincencing Agreement with Novartis for GlymaxX ADCC Technology 20
ProBioGen Enters Into Licensing Agreement With Merus For GlymaxX ADCC Technology 21
Probiogen AG, Key Competitors 22
Probiogen AG, Key Employees 23

List of Figures
Probiogen AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Probiogen AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Probiogen AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Probiogen AG, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Probiogen AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • General Dynamics United Kingdom Limited:企業の戦略・SWOT・財務情報
    General Dynamics United Kingdom Limited - Strategy, SWOT and Corporate Finance Report Summary General Dynamics United Kingdom Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Rehrig Pacific Company:企業の戦略的SWOT分析
    Rehrig Pacific Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Takuma Co Ltd (6013):企業の財務・戦略的SWOT分析
    Takuma Co Ltd (6013) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • United Biscuits (UK) Limited:企業の戦略・SWOT・財務情報
    United Biscuits (UK) Limited - Strategy, SWOT and Corporate Finance Report Summary United Biscuits (UK) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Stora Enso Oyj:戦略・SWOT・企業財務分析
    Stora Enso Oyj - Strategy, SWOT and Corporate Finance Report Summary Stora Enso Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • EDF Renewables Inc:企業の戦略的SWOT分析
    EDF Renewables Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Clean Harbors Inc (CLH):石油・ガス:M&Aディール及び事業提携情報
    Summary Clean Harbors Inc (Clean Harbors) is a provider of environmental, industrial and energy services. The company offers waste disposal and recycling, emergency response, chemical packing, field services, production services, exploration services, directional boring, lodging services and onsite …
  • National Institute of Agricultural Research-製薬・医療分野:企業M&A・提携分析
    Summary National Institute of Agricultural Research (INRA) is a research institute that conducts research in agriculture, food, nutrition and food safety, environment and land management. The institute provides healthcare services by conducting research in infectious diseases. It develops various co …
  • ELITechGroup Inc-医療機器分野:企業M&A・提携分析
    Summary ELITechGroup Inc (ELITech) is a medical device company that manufactures and distributes in vitro diagnostic equipment and reagents. The company’s products portfolio includes clinical chemistry, cytology, hematology, immunology, microbiology and molecular diagnostics. Its clinical chemistry …
  • Horiba Ltd (6856):企業の財務・戦略的SWOT分析
    Summary Horiba Ltd (Horiba) is a manufacturer of precision instruments and systems. The company's product portfolio includes automotive mechatronics, emission measurement systems, test systems, in vitro diagnostic systems, gas and oxygen analyzers, monitoring devices, industrial conductivity meters, …
  • Molecular Partners AG (MOLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Molecular Partners AG (Molecular Partners) is a clinical stage biopharmaceutical company that provides biological drugs. The company provides advanced pipeline products such as abicipar, a designed ankyrin repeat protein based anti-angiogenic drug developed for diabetic macular edema and wet …
  • Eternygen GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Eternygen GmbH (Eternygen) focuses on research and development of innovative drugs for dietary-related metabolic diseases.The company’s product development portfolio includes novel small molecule inhibitors, developed against the sodium coupled citrate transporter NaCT. It focuses research o …
  • Ocean Bio-Chem Inc (OBCI):企業の財務・戦略的SWOT分析
    Summary Ocean Bio-Chem Inc (OBCI) is a chemical manufacturing company that manufactures and markets maintenance and appearance products. The company's products include star brite products, performacide products, star tron products, and odor star products, among others. Its star tron products compris …
  • Monsanto Company:企業の戦略・SWOT・財務分析
    Monsanto Company - Strategy, SWOT and Corporate Finance Report Summary Monsanto Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sanquin Blood Supply Foundation:企業の戦略的SWOT分析
    Sanquin Blood Supply Foundation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Genalyte Inc-医療機器分野:企業M&A・提携分析
    Summary Genalyte Inc (Genalyte) is a healthcare service provider that develops cancer biomarker panels and testing platforms for screening. The company provides technologies such as the Maverick Detection System and Silicon Photonics Biosensor technology. Its Maverick Detection System quantifies the …
  • Reliance Capital Ltd:企業の戦略・SWOT・財務情報
    Reliance Capital Ltd - Strategy, SWOT and Corporate Finance Report Summary Reliance Capital Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Daniel Thwaites Plc:企業の戦略・SWOT・財務分析
    Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report Summary Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Fabric Development Inc:企業の戦略的SWOT分析
    Fabric Development Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Qorvo Inc (QRVO):企業の財務・戦略的SWOT分析
    Qorvo Inc (QRVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆